PATHWAY-2: spironolactone for resistant hypertension - Authors' reply. (2016)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(16)00698-x
PubMed Identifier: 27115814
Publication URI: http://europepmc.org/abstract/MED/27115814
Type: Journal Article/Review
Volume: 387
Parent Publication: Lancet (London, England)
Issue: 10026
ISSN: 0140-6736